RESEARCH-USE BIOSIMILAR ANTIBODY

Diridavumab

Monoclonal antibody · IgG1

Influenza A HA2IgG1RUO

Diridavumab is a monoclonal anti-HA stalk antibody. Diridavumab stabilizes the prefusion HA structure and prevents pH-dependent fusion of cellular and viral membranes in endosomes. Diridavumab can be used in research of H2 influenza virus.

TARGETInfluenza A HA2
YMonoclonal antibody
CATALOGSC-BS-625
CATALOG NUMBERSC-BS-625
MOLECULAR WEIGHTApprox. 144.2 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Diridavumab is a monoclonal anti-HA stalk antibody. Diridavumab stabilizes the prefusion HA structure and prevents pH-dependent fusion of cellular and viral membranes in endosomes. Diridavumab can be used in research of H2 influenza virus.

Diridavumab is a recombinant research-use antibody directed against Influenza A HA2.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Diridavumab | StellaCyte